Skip to content
Close
SEARCH
Let's Talk
Let's Talk

SOFTWARE
Discover Icon

Discover

Visualize rapid, validated insights through real-world data.
Activate Square

Activate

Streamline data preparation with guardrailed workflows.
Substantiate Square

Substantiate

Transform real-world data into decision-grade evidence.
Generate Square

Generate

Safeguard privacy and ensure utility with AI-driven technology.

SERVICES

PARTNERSHIPS

Aetion has entered into an agreement to be acquired by Datavant, a leading health data platform company.   Learn more → 

GettyImages-2155192216
AETION® SCIENCE AND RESEARCH

RWE Study Design and Execution

Comprehensive scientific services across the RWE study lifecycle

Let's Talk

Studies aligned to your needs

Aetion collaborates with you to design and execute real-world evidence (RWE) studies aligned to your needs. Our scientific team oversees the full study lifecycle, ensuring each output is methodologically sound, transparent, and built for confident decision-making.

We also provide strategic guidance to position your results effectively, addressing design or data nuances to help you maximize the value of your RWE investment.

Let's Talk
incidence and prevalence_sample results (1)

RWE for any asset at any stage

Prevalence and Incidence

Assess the incidence and prevalence of your indication of interest.
Treatment Patterns Characterize real world treatment patterns in the indicated population.
HCRU/Costs Quantify how often a population of interest uses healthcare services and costs of these services.
Comparative Effectiveness Compare the rate of clinical effectiveness endpoints between patients receiving and not receiving a therapy, device, or vaccine of interest (or a competitor therapy, device, or vaccine) using principled epidemiology and rigorous study design.
Comparative Safety Compare rates/risks of safety endpoints between patients receiving and not receiving a therapy, device, or vaccine of interest (or a competitor therapy, device, or vaccine) using principled epidemiology and rigorous study design.
Treatment Utilization Assess real world treatment utilization within an indicated patient population.
Patient Journey Characterize your indicated patient population’s use of routine healthcare services through various stages of disease progression.
Surrogate Endpoint Evaluation Evaluate the real world association between surrogate and clinical endpoints.
Adverse Event Contextualization Estimate the background rates of potential safety events in an indicated population.
Comparative HCRU/Costs Compare rates of healthcare use and/or costs between patients receiving and not receiving a therapy, device, or vaccine of interest (or a competitor therapy, device, or vaccine) using rigorous methods.
Natural History Estimate rates of clinical and effectiveness endpoints in your indicated population for clinical trial planning and benchmarking.
Quotes Green

“We needed speed, rigor, and clarity—and Aetion delivered on all three. Their team helped us go from concept to evidence in record time.”

Stakeholder, Pharma Partner

Experts in providing real-world evidence solutions

Connect with us to work with the team advancing critical decisions in healthcare.
Let's Talk